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Results

Myasthenia gravis (MG) is an autoimmune disease characterized
by weakness that increases with activity and improves with rest1.
Myasthenia Gravis generally worsens over a few years and often
progresses to affect the muscles of diaphragm leading to difficulty
breathing1.
Because Myasthenia is a disease of the immune system one of
the largest mainstays of treatment is immunosuppression2.
A complication of immune suppression is increased susceptibility
to infections3.
In particular, influenza infection has higher morbidity and mortality
in those who are immunosuppressed compared to the general
population3.
Those who are immunocompromised also take longer to resolve
the illness, leading to increased risk of complication as well as
increasing the chance that they could spread the flu3.
In multiple studies of both yearly flu vaccination as well as H1N1
specific vaccination for patients with MG, safety has been
established4,5,6.
40% of Myasthenic patients who contract an influenza-like illness
have worsening symptoms and fatigue7.
Current guidelines for flu vaccination recommend getting the flu
shot by the end of October8.
The CDC’s goal for flu vaccination is 90% or greater in adults
aged 18 and older9.
The average vaccination coverage of U.S. adults over 18 years of
age was 45.3%9.
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Graph A. Vaccination status of patients seen in the hospital but
without a Myasthenia Gravis Exacerbation

Patients Hospitalized With MG Exacerbation
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Problem Statement
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The goal of this study is to understand the timing and rate of
flu vaccination for patients with Myasthenia Gravis who were
hospitalized during this flu season at Lehigh Valley Health
Network (LVHN).
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Graph B. Vaccination status of patients seen in the hospital with
a Myasthenia Gravis exacerbation
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Graph C. Month flu vaccination received.

The overall purpose of this study was to better understand current
vaccination coverage of patients with MG, and to examine any link
between vaccination status and hospitalization due to MG
exacerbation.
We found that though most patients with MG who were in this
sample were vaccinated (55%), it still fell short of the 90% goal.
This should continue to be a target of research and improvement
because of the vulnerability of these patients to the influenza
virus.
In regard to a link between vaccination status, we found no
difference in vaccination rates between those that had a
myasthenic crisis and those who were hospitalized for a different
reason.
Future studies may attempt to increase vaccination rates in
patients with Myasthenia Gravis.
Possible efforts done in other systems include, paper fliers, mailed
reminders, patient scheduled vaccinations and television ads.
If the overall vaccination rate for patients with MG can be
improved it may lead to a stronger herd immunity, less
complications for the patients, and cost savings for the health
system.
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We found that overall. of the 92 charts (one was removed because they had
allergies to the flu shot) of patients with MG who had a hospital encounter
between September and January, 54% were vaccinated.
This falls well below the CDC goal of 90%.
Patients with MG are both more susceptible to and more impacted by the flu,
which can precipitate a life threatening myasthenic crisis.
This gap below the 90% goal also means that herd immunity has not been
reached within this subgroup of patients.
Despite falling short of the 90% mark, the population sampled still remains well
above the 45.3% vaccine coverage rates of the general population.
Possible reasons for this in the population sampled could be due to closer
physician follow up than the general population.
It also may reflect local efforts at LVHN to increase vaccination rate, including free
drive up flu drives.
However, the 36% gap in recommended vaccine coverage that remains
demonstrates that there are further steps that need to be taken in order to better
protect this vulnerable population.
The Fishers Exact Value was 1, higher than the 0.05 cutoff for significance,
indicating that vaccination status was independent of whether the patient was
hospitalized for an exacerbation of MG or not.
SELECT
This project exemplifies what results of a SELECT student’s education in the
health system domain.
In general, health systems are currently transitioning to a managed health
approach, especially at LVHN.
A managed health approach to care works to maintain the health of a population,
as well as provide targeted preventative care for at risk populations.
In this case, the vulnerable population is patients with Myasthenia Gravis and the
specific intervention is improving vaccine coverage.
Managed health allows the hospital to decrease admissions, have more space
available for patients in need, as well as saving money they may receive from
insurance companies to manage a group of patients.
The patients benefit by preventing unnecessary illness and possible myasthenic
crises.
They would also ideally benefit long term from decreased insurance costs if the
overall population is able to decrease medical costs by not getting the flu.
This topic of health systems and managed care is especially important for a
health care system to keep in mind as the medical landscape continues to
change.
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